Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pacira Pharmaceuticals Inc (NASDAQ:PCRX)

46.90
Delayed Data
As of Mar 24
 -0.05 / -0.11%
Today’s Change
29.95
Today|||52-Week Range
65.64
+45.20%
Year-to-Date

Stock Price Forecast

The 12 analysts offering 12-month price forecasts for Pacira Pharmaceuticals Inc have a median target of 59.00, with a high estimate of 89.00 and a low estimate of 38.00. The median estimate represents a +25.80% increase from the last price of 46.90.

Analyst Recommendations

The current consensus among 13 polled investment analysts is to Buy stock in Pacira Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.02
Sales
$70.9M
Reporting Date
May 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -119.44%
 
 
 
 
 
 
Growthannually -53.36%
 
 
 
 
 
 

Sales

Growthquarterly -2.72%
 
 
 
 
 
 
Growthannually 11.98%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.